Title: Michaelis-Menten kinetics
1Michaelis-Menten kinetics
V0 varies with S
Vmax approached asymptotically
V0 is moles of product formed per sec. when
P is low (close to zero time)
E S?ES?E P
Michaelis-Menten Model
V0 Vmax xS/(S Km)
Michaelis-Menten Equation
2Determining initial velocity (when P is low)
Ignore the back reaction
3Steady-state pre-steady-state conditions
At pre-steady-state, P is low (close to
zero time), hence, V0 for initial reaction
velocity
At equilibrium, no net change of S P or of
ES E
At pre-steady state, we can ignore the back
reactions
4Michaelis-Menten kinetics (summary)
Enzyme kinetics (Michaelis-Menten Graph) At
fixed concentration of enzyme, V0 is almost
linearly proportional to S when S is small,
but is nearly independent of S when S is large
k2
Proposed Model E S ? ES ? E P
ES complex is a necessary intermediate
Objective find an expression that relates rate
of catalysis to the concentrations of S E, and
the rates of individual steps
Start with V0 k2ES, and derive, V0 Vmax
xS/(S Km) This equation accounts for graph
data. At low S (S lt Km), V0 (Vmax/Km)S At
high S (S gt Km), V0 Vmax When S Km, V0
Vmax/2. Thus, Km substrate concentration
at which the reaction rate (V0) is half max.
5Range of Km values
Km provides approximation of S in vivo for many
enzymes
6Lineweaver-Burk plot (double-reciprocal)
7Allosteric enzyme kinetics
Sigmoidal dependence of V0 on S, not
Michaelis-Menten
Enzymes have multiple subunits and multiple
active sites Substrate binding may be cooperative
8Enzyme inhibition
9A competitive inhibitor
10Methotrexate
A competitive inhibitor of dihydrofolate
reductase - role in purine pyrimidine
biosynthesis
Used to treat cancer
11Tetrahydrofolate
Substrate for dihydrofolate reductase
12Kinetics of competitive inhibitor
Increase S to overcome inhibition Vmax
attainable, Km is increased
Ki dissociation constant for inhibitor
13Competitive inhibitor
Vmax unaltered, Km increased
14Kinetics of non-competitive inhibitor
Increasing S cannot overcome inhibition Less E
available, Vmax is lower, Km remains the same for
available E
15Noncompetitive inhibitor
Km unaltered, Vmax decreased
16Enzyme inhibition by DIPF
Group - specific reagents react with R groups of
amino acids
diisopropylphosphofluoridate
DIPF (nerve gas) reacts with Ser in
acetylcholinesterase
17Enzyme inhibition by iodoacetamide
A group - specific inhibitor
18Affinity inhibitor covalent modification
19Reactive analog
20Affinity inhibitor, bromoacetol phosphate
Active site modified
21Vitamins water-soluble
22Vitamins fat-soluble
23Structure of some water-soluble vitamins
Ascorbic acid is a reducing agent (an antioxidant)
B series are components of coenzymes, Must be
modified before they can serve their functions
24B5,transfers acyl group
25B2, oxidation - reduction
26C, reducing agent (antioxidant)
27B3, oxidation-reduction
28B6, group transfer to or from aas
29Prolyl hydroxylase ascorbate
4 - hydroxyproline required in collagen
(connective tissue in vertebrates) Scurvy from
ascorbate deficiency
On amino side of glycine
Enzyme has tightly bound Fe2 ion, which reacts
with O2 to form oxidized iron complex, which
inactivates enzyme, Ascorbate rescues enzyme by
reducing the ferric ion
30Forms of ascorbic acid
Ionized
Reduced
Oxidized
31Structure of some fat-soluble vitamins
32K1, blood coagulation
33A, vision, growth, reproduction
34E, antioxidant
35D, regulates calcium phosphate